Moglad Ehssan H
Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Alkharj 11942, Saudi Arabia.
Department of Microbiology, Medicinal and Aromatic Plants and Traditional Medicine Research Institute (MAPTMRI), National Center for Research, Khartoum, Sudan.
Saudi J Biol Sci. 2021 Mar;28(3):1835-1839. doi: 10.1016/j.sjbs.2020.12.029. Epub 2020 Dec 30.
Recently, we reported high antibacterial efficiency of (LA) against different standard strains of bacteria including Methicillin-Resistant (MRSA). Therefore, this study aimed to confirm the effectiveness of LA against clinically isolated (SA) including β-lactamase producer (Blac) and MRSA. Forty-eight SA isolates collected from various clinical samples were used in this study. Antibiotics susceptibility profile was determined for twenty different antibiotics using automated Microscan Walkaway 96 Plus system as recommended by Clinical and Laboratory Standards Institute (CLSI) guidelines. This system also identified β-lactamase producers and MRSA. In the meantime, LA ethanolic extract was fractionated using liquid-liquid fraction method to hexane, dichloromethane DCM and methanol 80% fractions. Antimicrobial activities of LA extract and fraction were performed with agar well diffusion method for all SA isolates, MIC and MBC were also recorded. Phytochemical screening for various phyto-constituent classes of LA ethanolic extract was determined. Out of 48 SA isolates, Cefoxitin-positive MRSA represent 31 (64.6%), Blac 17 (35.4%), and 41 (85.4%) were multidrug-resistant SA, which was resistant at least to one antibiotic from three different categories. All isolates were resistant to ampicillin and penicillin. Antimicrobial activities of LA extract and fractions revealed that ethanol extract was active against all isolated SA with inhibition zone ranged from 33 ± 2.00 to 25 ± 3.05 mm. While DCM exhibited the largest inhibition zone range from 37 ± 3.00 to 33 ± 2.00 mm. This study is first of its kind conforming the high antibacterial activity of LA against SA isolated from a different source of infection. The study concluded that LA extract and fractions are active and give positive result for all isolated SA. Therefore, suitable pharmacological formulation of LA extract as a promising antibacterial agent for the treatment of SA infection should be given extreme priority.
最近,我们报道了月桂酸(LA)对包括耐甲氧西林金黄色葡萄球菌(MRSA)在内的不同标准菌株具有高效抗菌活性。因此,本研究旨在确认月桂酸对临床分离的金黄色葡萄球菌(SA),包括产β-内酰胺酶菌株(Blac)和耐甲氧西林金黄色葡萄球菌的有效性。本研究使用了从各种临床样本中收集的48株金黄色葡萄球菌分离株。按照临床和实验室标准协会(CLSI)指南的建议,使用自动微生物扫描Walkaway 96 Plus系统测定了20种不同抗生素的药敏谱。该系统还鉴定了产β-内酰胺酶菌株和耐甲氧西林金黄色葡萄球菌。同时,采用液-液分离法将月桂酸乙醇提取物分离为己烷、二氯甲烷(DCM)和80%甲醇馏分。对所有金黄色葡萄球菌分离株采用琼脂孔扩散法测定月桂酸提取物及其馏分的抗菌活性,并记录最低抑菌浓度(MIC)和最低杀菌浓度(MBC)。对月桂酸乙醇提取物的各种植物成分类别进行了植物化学筛选。在48株金黄色葡萄球菌分离株中,头孢西丁阳性的耐甲氧西林金黄色葡萄球菌有31株(64.6%),产β-内酰胺酶菌株有17株(35.4%),41株(85.4%)为多重耐药金黄色葡萄球菌,至少对来自三个不同类别的一种抗生素耐药。所有分离株均对氨苄西林和青霉素耐药。月桂酸提取物及其馏分的抗菌活性表明,乙醇提取物对所有分离的金黄色葡萄球菌均有活性,抑菌圈范围为33±2.00至25±3.05毫米。而二氯甲烷的抑菌圈最大,范围为37±3.00至33±2.00毫米。本研究首次证实了月桂酸对从不同感染源分离的金黄色葡萄球菌具有高抗菌活性。研究得出结论,月桂酸提取物及其馏分具有活性,对所有分离的金黄色葡萄球菌均产生阳性结果。因此,应将月桂酸提取物合适的药理制剂作为治疗金黄色葡萄球菌感染的一种有前景的抗菌剂给予高度重视。